An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Crohn's Disease
type: MedicalStudy
description: A Placebo-Controlled, Dose-Ranging Study Followed by a Placebo-Controlled, Repeated-Dose Extension of Anti-TNF Chimeric Monoclonal Antibody (cA2) in the Treatment of Patients With Active Crohn's Disease
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE2,PHASE3
start date: 1995-06
end date: 1996-10
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00269854
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Centocor, Inc.
study subject: Crohn Disease
keywords: PHASE2,PHASE3
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Crohn Disease

AI Analytics
type: Organization